Parkinsonism treatment involves
**Core Concept**
Parkinsonism is a clinical syndrome characterized by tremors, bradykinesia, rigidity, and postural instability. It is primarily caused by the depletion of dopamine-producing neurons in the substantia nigra, a part of the basal ganglia. Treatment aims to restore dopamine levels or mimic its effects.
**Why the Correct Answer is Right**
The correct treatment for Parkinsonism involves the use of dopaminergic agents, such as levodopa, which crosses the blood-brain barrier and is converted into dopamine. This replenishes the depleted dopamine stores in the substantia nigra, thereby alleviating the symptoms of Parkinsonism. Other dopaminergic agents, like dopamine agonists (e.g., pramipexole) and MAO-B inhibitors (e.g., selegiline), work by directly stimulating dopamine receptors or preventing the breakdown of dopamine, respectively.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because anticholinergic agents, such as trihexyphenidyl, are used to treat Parkinsonism symptoms, but they are not the primary treatment. They work by blocking the action of acetylcholine, which is increased in Parkinsonism due to the loss of dopamine.
**Option B:** This option is incorrect because antipsychotics, such as haloperidol, can actually exacerbate Parkinsonism symptoms by blocking dopamine receptors. They are not used to treat Parkinsonism.
**Option C:** This option is incorrect because benzodiazepines, such as diazepam, are used to treat anxiety and insomnia, but they are not a primary treatment for Parkinsonism.
**Clinical Pearl / High-Yield Fact**
The "on/off" phenomenon is a characteristic feature of Parkinsonism treated with levodopa, where the patient experiences fluctuations in motor symptoms due to the unpredictable absorption and conversion of levodopa into dopamine.
**Correct Answer: A. Levodopa**